Home/Filings/4/0001054833-13-000032
4//SEC Filing

COVENTRY HEALTH CARE INC 4

Accession 0001054833-13-000032

CIK 0001054833operating

Filed

May 7, 8:00 PM ET

Accepted

May 8, 7:18 PM ET

Size

31.1 KB

Accession

0001054833-13-000032

Insider Transaction Report

Form 4
Period: 2013-05-07
Transactions
  • Disposition to Issuer

    Common Stock

    2013-05-071,1250 total(indirect: By Spouse)
  • Disposition to Issuer

    Common Stock

    2013-05-0734,5750 total
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2013-05-0716,9420 total
    Exercise: $14.88Exp: 2019-01-01Common Stock (16,942 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2013-05-074,5000 total
    Exercise: $19.91Exp: 2013-06-05Common Stock (4,500 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2013-05-076,4800 total
    Exercise: $24.29Exp: 2020-01-01Common Stock (6,480 underlying)
  • Award

    Restricted Stock Units

    2013-05-07+835,215 total
    Common Stock (83 underlying)
  • Disposition to Issuer

    Common Stock Restricted

    2013-05-0730,3730 total
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2013-05-073,3620 total
    Exercise: $50.05Exp: 2017-01-01Common Stock (3,362 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2013-05-072,7430 total
    Exercise: $56.96Exp: 2016-01-01Common Stock (2,743 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2013-05-075,2150 total
    Common Stock (5,215 underlying)
Footnotes (10)
  • [F1]Common stock of Coventry Health Care, Inc. (the Company) disposed of pursuant to the Agreement and Plan of Merger, dated as of August 19, 2012, as amended, among Aetna Inc. (Aetna), the Company and Jaguar Merger Subsidiary, Inc. (the Merger Agreement). Each share of the Companys common stock was exchanged for $27.30 in cash and .3885 share of Aetna common stock. The shares of Aetna common stock received pursuant to the Merger Agreement have a market value of $57.93, which was calculated by taking the average of the volume weighted average of the trading prices for Aetnas common stock on the New York Stock Exchange for each of the five trading days ending on the trading day that is two trading days prior to the completion of the merger (the Aetna Stock Price).
  • [F10]Represents restricted stock units, which were cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the product of (A) the Equity Award Cash Consideration and (B) the number of shares of Company common stock underlying the restricted stock units.
  • [F2]Common stock of the Company, held indirectly by spouse, disposed of pursuant to the Merger Agreement. Each share of the Companys common stock was exchanged for $27.30 in cash and .3885 share of Aetna common stock valued at the Aetna Stock Price.
  • [F3]Restricted Common stock, with all restrictions lapsed, of the Company disposed of pursuant to the Merger Agreement. Each share of the Companys common stock was exchanged for $27.30 in cash and .3885 share of Aetna common stock valued at the Aetna Stock Price.
  • [F4]This option, which provided for vesting in equal quarterly installments over a one-year period beginning April 1, 2009, was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the product of (A) the excess of (1) the sum of (x) $27.30 plus (y) the value equal to the product of the Aetna Stock Price ($57.93) multiplied by .3885 (which sum of the amounts in clauses (x) and (y) equals $49.80 and is referred to as the Equity Award Cash Consideration) over (2) the exercise price of the option and (B) the total number of shares of Company common stock subject to the option.
  • [F5]This option, which provided for vesting six months after the grant date on December 5, 2003, was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the product of (A) the excess of (1) the Equity Award Cash Consideration over (2) the exercise price of the option and (B) the total number of shares of Company common stock subject to the option.
  • [F6]This option, which provided for vesting in equal quarterly installments over a one-year period beginning April 1, 2010, was cancelled pursuant to the Merger Agreement in exchange for a cash payment representing the product of (A) the excess of (1) the Equity Award Cash Consideration over (2) the exercise price of the option and (B) the total number of shares of Company common stock subject to the option.
  • [F7]This option, which provided for vesting in equal quarterly installments over a one-year period beginning April 1, 2008, had an exercise price in excess of the Equity Award Cash Consideration and was cancelled pursuant to the Merger Agreement in exchange for a cash payment to be paid within 10 days after the closing of the merger. The cash payment represents the product of (A) $2.25 and (B) the total number of shares of Company common stock subject to the option.
  • [F8]This option, which provided for vesting in equal quarterly installments over a one-year period beginning April 1, 2007, had an exercise price in excess of the Equity Award Cash Consideration and was cancelled pursuant to the Merger Agreement in exchange for a cash payment to be paid within 10 days after the closing of the merger. The cash payment represents the product of (A) $1.25 and (B) the total number of shares of Company common stock subject to the option.
  • [F9]Represents cash dividends credited to reporting persons Stock Deferral Account and converted into whole restricted stock units in accordance with the terms and conditions of the Companys Deferred Compensation Plan for Non-Employee Directors.

Issuer

COVENTRY HEALTH CARE INC

CIK 0001054833

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001054833

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 7:18 PM ET
Size
31.1 KB